Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: A phase II study

AIM: To improve the results of New therapeutic strategies in hepatocellular carcinoma (HCC). We have conducted a phase II study with pegylated liposomal doxorubicin (PLD), 5-fluorouracil (5FU) and folinic acid (FA). METHODS: Thirty-one patients with hystologically-confirmed, inoperable HCC, received...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:World J Gastroenterol
Hoofdauteurs: Lorenzo, Giuseppe Di, Rea, Antonio, Carlomagno, Chiara, Pepe, Stefano, Palmieri, Giovannella, Labianca, Roberto, Chirianni, Antonio, Stefano, Alfonso De, Esposito, Vincenzo, Placido, Sabino De, Montesarchio, Vincenzo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Baishideng Publishing Group Co., Limited 2007
Onderwerpen:
Rapid Communication
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4611295/
https://ncbi.nlm.nih.gov/pubmed/18161926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v13.i48.6553
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items